Roche will develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR). Roche tissue diagnostics head Jill German
The post Roche partners with Merck to develop companion diagnostic test appeared first on Compelo Medical Devices.
Original Article: Roche partners with Merck to develop companion diagnostic test